MENU
+Compare
TXG
Stock ticker: NASDAQ
AS OF
Oct 27, 03:32 PM (EDT)
Price
$13.65
Change
-$0.12 (-0.87%)
Capitalization
1.71B

TXG 10x Genomics Forecast, Technical & Fundamental Analysis

10x Genomics Inc is a life science technology company based in the United States... Show more

TXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TXG with price predictions
Oct 24, 2025

Momentum Indicator for TXG turns positive, indicating new upward trend

TXG saw its Momentum Indicator move above the 0 level on October 20, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TXG's RSI Oscillator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TXG just turned positive on October 16, 2025. Looking at past instances where TXG's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

TXG moved above its 50-day moving average on October 23, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TXG advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for TXG crossed bearishly below the 50-day moving average on September 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TXG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TXG broke above its upper Bollinger Band on October 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TXG entered a downward trend on October 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.217) is normal, around the industry mean (22.364). P/E Ratio (0.000) is within average values for comparable stocks, (84.241). TXG's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.649). TXG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (2.614) is also within normal values, averaging (71.569).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TXG is expected to report earnings to fall 203.07% to -28 cents per share on November 06

10x Genomics TXG Stock Earnings Reports
Q3'25
Est.
$-0.29
Q2'25
Beat
by $0.65
Q1'25
Beat
by $0.19
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.04
The last earnings report on August 07 showed earnings per share of 28 cents, beating the estimate of -37 cents. With 624.72K shares outstanding, the current market capitalization sits at 1.71B.
A.I. Advisor
published General Information

General Information

a life science technology company, which engages in building products to interrogate, understand and master biology

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
6230 Stoneridge Mall Road
Phone
+1 925 401-7300
Employees
1259
Web
https://www.10xgenomics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIEAX15.710.12
+0.77%
MM S&P 500® Index R4
FIADX60.220.40
+0.67%
Fidelity Advisor International Discv I
EISAX30.660.16
+0.52%
Carillon ClariVest Intl Stock A
CFGIX19.320.09
+0.47%
Cromwell Foresight Global Infras Instl
SSDCX26.280.10
+0.38%
DWS Small Cap Growth C

TXG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TXG has been loosely correlated with COIN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TXG jumps, then COIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXG
1D Price
Change %
TXG100%
+3.07%
COIN - TXG
56%
Loosely correlated
+9.82%
CLSK - TXG
54%
Loosely correlated
+9.59%
RIOT - TXG
54%
Loosely correlated
+4.54%
COMP - TXG
52%
Loosely correlated
+4.69%
GEHC - TXG
50%
Loosely correlated
+1.18%
More

Groups containing TXG

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXG
1D Price
Change %
TXG100%
+3.07%
Health Services
category (425 stocks)
-3%
Poorly correlated
+0.56%
Services to the Health Industry
category (92 stocks)
-3%
Poorly correlated
+0.24%